KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 0.03%.

  • Biogen's Return on Invested Capital fell 200.0% to 0.03% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.03%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.04% for FY2025, which is 200.0% down from last year.
  • According to the latest figures from Q4 2025, Biogen's Return on Invested Capital is 0.03%, which was down 200.0% from 0.02% recorded in Q3 2025.
  • Biogen's Return on Invested Capital's 5-year high stood at 0.17% during Q1 2021, with a 5-year trough of 0.05% in Q4 2023.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.01% (2023), whereas its average is 0.04%.
  • As far as peak fluctuations go, Biogen's Return on Invested Capital crashed by -2200bps in 2021, and later skyrocketed by 400bps in 2024.
  • Biogen's Return on Invested Capital (Quarter) stood at 0.16% in 2021, then tumbled by -38bps to 0.1% in 2022, then tumbled by -152bps to 0.05% in 2023, then soared by 68bps to 0.02% in 2024, then crashed by -101bps to 0.03% in 2025.
  • Its Return on Invested Capital was 0.03% in Q4 2025, compared to 0.02% in Q3 2025 and 0.02% in Q2 2025.